Pfizer’s decision to cut its early-stage cancer asset was due to “strategic business reasons” and not driven by safety or ...

Pfizer, by contrast, appears diversified but diffuse—its pipeline may contain value, but that value is not yet organized into ...

Pfizer Inc. (NYSE: PFE) will present new data across its diverse, industry-leading Oncology pipeline and portfolio at the American Society of Clinical Oncology (ASCO) Annual Meeting, May 29 – June 2, ...

The vaccine candidate is the furthest any shot has gotten since the last one was pulled in 2002. Scientists are testing other ...

NEW YORK, June 24 /PRNewswire/ — Underscoring its commitment to scientific advancement, Pfizer Inc will launch Think Science Now, a science awareness program to promote exceptional researchers who ...

The Trump administration’s dramatic reworking of U.S. public-health agencies’ approach to vaccines is creating a difficult and unpredictable situation for drugmakers. Pfizer, in particular, could be ...

Pharmaceutical companies are keen to have a stake in the personalized medicine market, viewed as a growing trend in the future of healthcare and a significant source of life science innovation. As ...

Lisa Talbot, who served as chief client officer at 2025 MM+M Agency 100 honoree MSL, was named president of Spectrum Science ...

Pfizer Inc. (NYSE: PFE) CEO Albert Bourla sharply criticized Robert F. Kennedy's views on vaccines, calling them "anti-science." He suggested that meaningful progress on immunization policy would ...

While this year’s Super Bowl will be filled with more pharma ads than ever before, one big name will be missing from the roster. Pfizer, which has run ads during the Big Game for the past two years, ...

Pfizer's CEO defended the safety and efficacy of its COVID vaccine and suggested President Trump deserves the Nobel Peace Prize for his role in its development. Why it matters: Trump on Monday ...